Rare Diseases and the Changing NHS

Expert insight on how NHS reform, funding pressures and system shifts are shaping Rare Disease care in 2026

Masterclass Details:

Rare Disease care continues to sit at the intersection of innovation, complexity and unmet need. As NHS reform progresses through 2026, the landscape for Rare Disease pathways, specialised commissioning and funding decisions is shifting in ways that directly affect patients, providers and Life Sciences organisations.

In this 60-minute masterclass, join our panel of leading voices in Rare Diseases and market access as they explore how NHS changes are influencing national, regional and local decision-making.

We will share perspectives on access challenges, evolving commissioning responsibilities, data and evidence expectations and the practical realities shaping Rare Disease care across the UK.

This session will help you understand how Rare Disease services are adapting to system pressures and policy reform and how Life Sciences teams can support sustainable, patient-centred delivery in a changing environment.

Join live to hear a range of expert perspectives, ask your questions and gain practical insight into how Rare Disease care is responding to NHS reform in 2026.

Key Learning Objectives:

Review current NHS policy changes and their impact on Rare Disease funding and patient care
Understand how national, regional and local decision-making is evolving in Rare Disease pathways
Explore strategies for navigating changes in specialised commissioning and access
Identify challenges and opportunities created by system reform, evidence expectations and data need
Develop practical approaches to support improved outcomes in a changing Rare Disease environment